Reduction of the incidence and mortality of rectal cancer by polypectomy: A prospective cohort study in Haining County

World Journal of Gastroenterology

Volumn 8, Issue 3, 2002, Pages 488-492

  Zheng, Shu ^a   Liu, Xi Yong ^a   Ding, Ke Feng ^a   Wang, Lin Bo ^a   Qiu, Pei Lin ^a   Ding, Xin Feng ^a   Shen, Yong Zhou ^a   Shen, Gao Fei ^a   Sun, Qi Rong ^a   Li, Wei Dong ^a   Dong, Qi ^a   Zhang, Su Zhan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CHINA; CLINICAL TRIAL; COHORT ANALYSIS; COLON ADENOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POLYPECTOMY; POPULATION RESEARCH; PROSPECTIVE STUDY; RECTUM ADENOMA; RECTUM CANCER;

EID: 0036280793     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i3.488     Document Type: Article

References (50)

1. Cancer statistics, 1999
2. Cancer statistics, 1998
3. Analyses of variation trend and short term detection of Chinese malignant tumor mortality during twenty years
4. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
5. Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study
6. Chemoprevention of colorectal cancer
7. The effect of fecal occult-blood screening on the incidence of colorectal cancer
8. Faecal occult blood screening for colorectal cancer at Nottingham: Details of the verification process
9. A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds
10. Colorectal cancer: Molecules and populations
11. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer
12. Carbohydrates and colorectal cancer risk among Chinese in North America
13. Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction?
14. Screening and surveillance for colorectal cancer
15. Natural history of colorectal cancer
16. The advanced adenoma as the primary target of screening
17. Adenoma-carcinoma sequence or "de novo" carcinogenesis? A study of adenoma remnants in a population-based series of large bowel cancer
18. Monitoring colorectal cancer after surgical resection
19. American Cancer Society guidelines for the early detection of cancer
20. American Cancer Society guidelines for the early detection of cancer: Update of early detection gudelines for prostate, colorectal, and endometrial cancers. Also: Update 2001 - Testing for early lung cancer detection
21. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer
22. Early detection and early diagnosis for colorectal cancer
23. Evaluation of RPHA fecal occult blood test in screening for colorectal cancer
24. Evaluation of digestive malignant tumor screening methods
25. Pathologic features of initial adenoma as predictors for metachronous adenomas of the rectum
26. Dynamic Observation on 2815 cases of recto-anal adenoma and polyps for 10 years
27. Screening for colorectal cancer in a high-risk population: Result of a mathematical model
28. A community-based program of colorectal screening in an asymptomatic population: Evaluation of screening tests and compliance
29. Fecal occult blood test screening for colorectal cancer
30. Fecal occult blood screening for colorectal cancer: Open issues
31. Fecal occult blood testing for colorectal screening: Use the finger
32. Screening for colorectal cancer: What is the most cost-effective approach?
33. The effect of fecal occult-blood screening on the incidence of colorectal cancer
34. Colorectal cancer screening
35. What can we conclude from the randomized controlled trials of fecal occult blood test screening?
36. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?
37. Using colonoscopy to screen for colorectal cancer
38. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening
39. The risks of screening: Data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer
40. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test
41. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study
42. The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests
43. Randomized population study of screening for intestinal cancer with Hemoccult-II
44. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994
45. Cancer incidence trends in urban Shanghai, 1972-1994: An update
46. Evaluation of the application of the optimized colorectal cancer screening protocol in high-risk population
47. Progress in colorectal cancer research in China
48. Recent study on colorectal cancer in China
49. Cancer statistics, 2000
50. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer